326 related articles for article (PubMed ID: 34415574)
21. Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation.
Thor M; Fitzgerald K; Apte A; Oh JH; Iyer A; Odiase O; Nadeem S; Yorke ED; Chaft J; Wu AJ; Offin M; Simone Ii CB; Preeshagul I; Gelblum DY; Gomez D; Deasy JO; Rimner A
Radiother Oncol; 2024 Jan; 190():109983. PubMed ID: 37926331
[TBL] [Abstract][Full Text] [Related]
22. An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.
Ma Y; Li Q
Cancer Radiother; 2023 Dec; 27(8):705-711. PubMed ID: 37932182
[TBL] [Abstract][Full Text] [Related]
23. Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases.
Cheung BMF; Lau KS; Lee VHF; Leung TW; Kong FS; Luk MY; Yuen KK
Radiat Oncol J; 2021 Dec; 39(4):254-264. PubMed ID: 34986546
[TBL] [Abstract][Full Text] [Related]
24. Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy.
Hirose TA; Arimura H; Ninomiya K; Yoshitake T; Fukunaga JI; Shioyama Y
Sci Rep; 2020 Nov; 10(1):20424. PubMed ID: 33235324
[TBL] [Abstract][Full Text] [Related]
25. Integration of Risk Survival Measures Estimated From Pre- and Posttreatment Computed Tomography Scans Improves Stratification of Patients With Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
Jiao Z; Li H; Xiao Y; Aggarwal C; Galperin-Aizenberg M; Pryma D; Simone CB; Feigenberg SJ; Kao GD; Fan Y
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1647-1656. PubMed ID: 33333202
[TBL] [Abstract][Full Text] [Related]
26. Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Li H; Galperin-Aizenberg M; Pryma D; Simone CB; Fan Y
Radiother Oncol; 2018 Nov; 129(2):218-226. PubMed ID: 30473058
[TBL] [Abstract][Full Text] [Related]
27. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy.
Lafata KJ; Hong JC; Geng R; Ackerson BG; Liu JG; Zhou Z; Torok J; Kelsey CR; Yin FF
Phys Med Biol; 2019 Jan; 64(2):025007. PubMed ID: 30524018
[TBL] [Abstract][Full Text] [Related]
28. Ct-based subregional radiomics using hand-crafted and deep learning features for prediction of therapeutic response to anti-PD1 therapy in NSCLC.
Hu Y; Jiang T; Wang H; Song J; Yang Z; Wang Y; Su J; Jin M; Chang S; Deng K; Jiang W
Phys Med; 2024 Jan; 117():103200. PubMed ID: 38160516
[TBL] [Abstract][Full Text] [Related]
29. Prediction of SBRT response in liver cancer by combining original and delta cone-beam CT radiomics: a pilot study.
Yang P; Shan J; Ge X; Zhou Q; Ding M; Niu T; Du J
Phys Eng Sci Med; 2024 Mar; 47(1):295-307. PubMed ID: 38165634
[TBL] [Abstract][Full Text] [Related]
30. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
[TBL] [Abstract][Full Text] [Related]
31. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
32. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Starkov P; Aguilera TA; Golden DI; Shultz DB; Trakul N; Maxim PG; Le QT; Loo BW; Diehn M; Depeursinge A; Rubin DL
Br J Radiol; 2019 Feb; 92(1094):20180228. PubMed ID: 30457885
[TBL] [Abstract][Full Text] [Related]
33. Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding.
Khodabakhshi Z; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):713-725. PubMed ID: 37599160
[TBL] [Abstract][Full Text] [Related]
34. Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung Cancer.
Bertolini M; Trojani V; Botti A; Cucurachi N; Galaverni M; Cozzi S; Borghetti P; La Mattina S; Pastorello E; Avanzo M; Revelant A; Sepulcri M; Paronetto C; Ursino S; Malfatti G; Giaj-Levra N; Falcinelli L; Iotti C; Iori M; Ciammella P
Curr Oncol; 2022 Jul; 29(8):5179-5194. PubMed ID: 35892979
[TBL] [Abstract][Full Text] [Related]
35. Radiomic analysis for early differentiation of lung cancer recurrence from fibrosis in patients treated with lung stereotactic ablative radiotherapy.
Kunkyab T; Mou B; Jirasek A; Haston C; Andrews J; Thomas S; Hyde D
Phys Med Biol; 2023 Aug; 68(16):. PubMed ID: 37164024
[No Abstract] [Full Text] [Related]
36. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
[TBL] [Abstract][Full Text] [Related]
37. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
[TBL] [Abstract][Full Text] [Related]
38. Deep learning PET/CT-based radiomics integrates clinical data: A feasibility study to distinguish between tuberculosis nodules and lung cancer.
Zhang X; Dong X; Saripan MIB; Du D; Wu Y; Wang Z; Cao Z; Wen D; Liu Y; Marhaban MH
Thorac Cancer; 2023 Jul; 14(19):1802-1811. PubMed ID: 37183577
[TBL] [Abstract][Full Text] [Related]
39. Electron Density and Biologically Effective Dose (BED) Radiomics-Based Machine Learning Models to Predict Late Radiation-Induced Subcutaneous Fibrosis.
Avanzo M; Pirrone G; Vinante L; Caroli A; Stancanello J; Drigo A; Massarut S; Mileto M; Urbani M; Trovo M; El Naqa I; De Paoli A; Sartor G
Front Oncol; 2020; 10():490. PubMed ID: 32373520
[No Abstract] [Full Text] [Related]
40. A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Franceschini D; Cozzi L; De Rose F; Navarria P; Fogliata A; Franzese C; Pezzulla D; Tomatis S; Reggiori G; Scorsetti M
Strahlenther Onkol; 2020 Oct; 196(10):922-931. PubMed ID: 31722061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
